Funding
Horizon 2020
Training network to advance integrated computational simulations in translational medicine, applied to intervertebral disc degeneration (Disc4All)
Funding Agency: EU Horizon 2020
Project ID: H2020-MSCA-ITN-2020-955735
Total Project Budget: cost reimbursement for partners
Project Duration: 11/1/2020–10/31/2024
UNYTE
TRPC6 as a diagnostic biomarker and therapeutic target in scleroderma
Funding Agency: UNYTE
Project ID: UL1 TR00
Total Project Budget: $10,000
Project Duration: 8/1/2021 – 5/30/2022
Swiss National Science Foundation
Functional role of Toll-like receptor associated microRNAs in IVD pathophysiology
Funding Agency: Swiss National Science Foundation
Project ID: 310030_185240
Total Project Budget: $256,000
Project Duration: 5/1/2019 – 10/31/2023
National Scleroderma Foundation
A novel 3D scleroderma skin model to test therapeutic TRPC6 Modulation
Funding Agency: National Scleroderma Foundation
Total Project Budget: $30,000
Project Duration: 4/2022 – 7/2022
National Institute of General Medical Sciences
Substrate Stiffness, Topography, and TRPV4 in AF Mechanotransduction
Funding Agency: NIH NIGMS
Project ID: 1 R16 GM146717-01
Total Project Budget: $730,462
Project Duration: 9/2022 – 08/2026
Department of Defense: CDMRP
A novel 3D scleroderma skin model to test therapeutic TRPC6 modulation
Funding Agency: DoD CDMRP
Project ID: SL20014
Total Project Budget: $410,000
Project Duration: 7/2022 – 6/2025
National Science Foundation
FMSG: Bio: Advancing Extracellular Vesicle Biomanufacturing of CRISPR-Edited Human iPSC-derived MSCs with Next-Generation Purification
Funding Agency: NSF
Project ID: 2229111
Total Project Budget: $500,000
Project Duration: 1/2023 – 12/2024
In Collaboration with Syracuse University